Exabis Library
Welcome to the e-CCO Library!
P251: Comparison of 3 magnetic resonance enterography indices for detection of activity and severity in Crohn’s disease
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P251: Endoscopic and pathologic findings of the esophago-gastroduodenal involvement of Crohn’s disease in Korea: a prospective cohort study
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P251: High anti-TNF drugs trough levels are not associated with the occurrence of adverse events in patients with inflammatory bowel diseases
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P251: Level of Interleukin-17 in Inflammatory Bowel Disease and Its relation to disease activity.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P251: RAID Dx: the first test based on faecal microbiota to differentiate irritable bowel syndrome from inflammatory bowel diseases
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P251: The contribution of clinical and psychosocial factors to fatigue in 182 patients with inflammatory bowel disease: a cross-sectional study
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P252 The cardiovascular risk profile in patients with inflammatory bowel disease: A cross-sectional single-centre study (the CARE-IBD study)
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P252: Assessment of ulcerative colitis using histological indexes
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P252: Elevated C-reactive protein level during clinical remission can predict poor outcomes in patients Crohn's disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P252: Is the time for chromoendoscopy spreading in dysplasia surveillance of inflammatory bowel diseases? A systematic review with meta-analysis
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P252: Low adherence is associated with worse disease course in Ulcerative Colitis: a retrospective study from a single referral center.
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P252: Measuring the mediating effects of Mayo score components for tofacitinib on disease-specific quality of life in ulcerative colitis: data from the OCTAVE programme
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P252: Medication adherence in inflammatory bowel diseases in the era of biotherapies
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P252: Solid organ transplant (with the exception of liver) in patients with inflammatory bowel disease: An ECCO CONFER Multicentre Case Series
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P253 The prevalence of type 6 herpes with polyps in patients with inflammatory bowel disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P253: A qualitative study exploring meaningful improvement in bowel urgency among adults with moderate to severe Ulcerative Colitis.
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P253: Are we doing enough to prevent colectomy in Inflammatory Bowel Disease (IBD) patients? A 5-year review of colectomy rates in Shropshire and Mid-Wales UK (2015-2019).
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P253: Characteristics of patients with Crohn’s disease diagnosed in the emergency department: Experience in a single tertiary hospital
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P253: Effects of time on urinary metabolic signatures in inflammatory bowel disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P253: Histological Remission and Activity as Predictor of Relapse, Hospitalization, and Surgery in Ulcerative Colitis: Systematic Review and Meta-analysis
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM